Literature DB >> 10318324

Pragmatic versus explanatory trials.

K D MacRae.   

Abstract

This article considers the distinction between "explanatory" and "pragmatic" aims in clinical trials--the distinction between testing a biological hypothesis and providing evidence to permit a choice between alternative treatment policies. The choice of treatments to compare, the selection of patients for the trial, the study size, and how the treatment comparison should be made are among the matters discussed. In general, where explanatory and pragmatic aims conflict, the pragmatic aim will often take priority.

Entities:  

Mesh:

Year:  1989        PMID: 10318324     DOI: 10.1017/s0266462300007406

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  9 in total

1.  A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.

Authors:  L Garattini; R Grilli; D Scopelliti; L Mantovani
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

2.  Using health technology assessment to identify research gaps: an unexploited resource for increasing the value of clinical research.

Authors:  N Ann Scott; Carmen Moga; Christa Harstall; Jacques Magnan
Journal:  Healthc Policy       Date:  2008-02

3.  An effectiveness evaluation of a multifaceted preventive intervention on occupational injuries in foundries: a 13-year follow-up study with interrupted time series analysis.

Authors:  Stefano Porru; Stefano Calza; Cecilia Arici
Journal:  Int Arch Occup Environ Health       Date:  2011-04-17       Impact factor: 3.015

4.  [Clinical outcomes, health-related quality of life, and cost-effectiveness of a 6-month community- based lifestyle program for adults at increased cardiovascular risk in lower Austria].

Authors:  Ursula Reichenpfader; Kylie Thaler; Anke Richter; Patricia Thieda; Gerald Gartlehner
Journal:  Wien Med Wochenschr       Date:  2012-08-28

Review 5.  Mesh fixation in endoscopic inguinal hernia repair: evaluation of methodology based on a systematic review of randomised clinical trials.

Authors:  Hans Lederhuber; Franziska Stiede; Stephan Axer; Ursula Dahlstrand
Journal:  Surg Endosc       Date:  2017-04-14       Impact factor: 4.584

6.  Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2011-07       Impact factor: 4.558

7.  Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates.

Authors:  Thomas R Fanshawe; A Toby Prevost; J Scott Roberts; Robert C Green; David Armstrong; Theresa M Marteau
Journal:  Genet Test       Date:  2008-09

8.  Proof of impact and pipeline planning: directions and challenges for social audit in the health sector.

Authors:  Neil Andersson
Journal:  BMC Health Serv Res       Date:  2011-12-21       Impact factor: 2.655

9.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.

Authors:  Marshall Godwin; Lucia Ruhland; Ian Casson; Susan MacDonald; Dianne Delva; Richard Birtwhistle; Miu Lam; Rachelle Seguin
Journal:  BMC Med Res Methodol       Date:  2003-12-22       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.